Relationship of thyroid status to growth hormone and insulin-like growth factor-I (IGF-I) in plasma and IGF-I mRNA in liver and skeletal muscle of cattle

Steers were made hyperthyroid or hypothyroid to study the effects of physiological alterations in thyroid hormone status on plasma growth hormone (GH) profiles, plasma insulin-like growth factor-I (IGF-I) concentrations, and relative abundance of IGF-I mRNA in skeletal muscle and liver. Eighteen yearling crossbred steers (360 to 420 kg) were randomly allotted to hyperthyroid (subcutaneous injection 0.6 μg/kg BW L-thyroxine for 10 d), hypothyroid (oral thiouracil; 0.25% diet plus 12.5 g capsule/d for 17 d), or control (subcutaneous injection 0.9% NaCl) treatment groups. Blood samples were taken for measurement of GH, IGF-I, thyroxine (T₄) and triiodothyronine (T₃) by RIA. Samples of liver and skeletal muscle were taken by biopsy for measurement of IGF-I mRNA by solution hybridization. Steers receiving thiouracil had 57 and 53% (P<.05) lower T₄ and T₃, respectively, than control steers (84.1 and 1.7 ng/ml). The hyperthyroid steers had 228 and 65% greater (P<.05) T₄ and T₃ than control steers. Neither increased nor decreased thyroid status had any significant effects on plasma GH profiles, liver IGF-I mRNA, or plasma concentration of IGF-I. There was no effect of thyroid hormone alteration on skeletal muscle IGF-I mRNA concentrations. The results of this study suggest that short-term changes in thyroid status of cattle had no major impact on the GH-IGF-I axis or skeletal muscle IGF-I mRNA.     

Evidence that bovine growth hormone treatment increases the rate of extrathyroidal 5'-monodeiodinase activity in cattle

This study examined the influence of bovine growth hormone (bGH) on liver and kidney thyroxine-5'-monodeiodinase activity (TMA) in growing beef cattle. In a preliminary trial (trial 1), tissue samples were obtained at slaughter from two placebo-injected and two bGH-injected (29.2 IU/day for 14 days before slaughter) Hereford heifers (398 kg avg slaughter wt), with one heifer on each treatment fed at either 1.0 or 2.0 times maintenance energy requirement. In a second trial, tissue and plasma samples were obtained from six placebo-injected and six bGH-injected (29.2 IU/day for 19 days) Hereford steers (331 kg avg slaughter wt) fed at 1.8 times maintenance energy requirement. In a third trial, liver tissue and plasma samples were obtained from 14 Angus X Hereford steers (270 kg avg wt) fed either an 8% protein, 1.96 Mcal-metabolizable energy/kg diet (8 steers) or a 14% protein, 2.67 Mcal-metabolizable energy/kg diet (6 steers) in association with acute administration of bGH. Half the steers in each group were given two injections per steer of either placebo or 37.8 IU bGH at 24-hr intervals and slaughtered 24 hr after the second injection. Units of tissue TMA in all trials were measured at slaughter; one unit defined as 1 ng T3 generated/hr/mg protein during incubation with T4 (1.3 fM). In trial 1, TMA in liver and kidney was 2.86 and 1.21 times greater, respectively, for bGH than for placebo treatments. In trial 2, units of TMA in liver homogenates were higher (P less than .05) for bGH (4.14) than for placebo (2.83) treatments and higher (P less than .02) in liver microsomal preparations for bGH (32.7) than for placebo (27.3) treatments. Units of TMA in kidney homogenates were also higher (P less than .10) for bGH (1.48) than for placebo (.87) treatments and higher (P less than .02) in kidney microsomal preparations for bGH (23.0) than for placebo (16.4) treatments. Following acute injection of bGH (trial 3), units of TMA in liver homogenates were higher (P less than .01) for bGH (2.5) than for placebo (1.8) treatments. Plasma T4 (70.0 vs 73.5 ng/ml) and T3 (1.08 vs 1.18 ng/ml) concentrations appeared slightly higher in bGH-treated steers (trial 2) and increased by 20 and .5 ng/ml, respectively, (P less than .01) within 6 to 12 h after acute injection of bGH (trial 3). Concurrently, plasma TSH concentration increased following acute GH injection (trial 3).(ABSTRACT TRUNCATED AT 400 WORDS)     

Effects of cimaterol administration on plasma concentrations of various hormones and metabolites in friesian steers

The aim of the experiment was to determine the acute and chronic effects of the β-agonist, cimaterol, on plasma hormone and metabolite concentrations in steers. Twelve Friesian steers (liveweight = 488 ± 3 kg) were randomly assigned to receive either 0 (control; n=6) or .09 mg cimaterol/kg body weight/day (treated; n=6). Steers were fed grass silage ad libitum. Cimaterol, dissolved in 140 ml of acidified distilled water (pH 4.2), was administered orally at 1400 hr each d. After 13 d of treatment with cimaterol or vehicle (days 1 to 13), all animals were treated with vehicle for a further 7 d (days 14 to 20). On days 1, 13 and 20, blood samples were collected at 20 min-intervals for 4 hr before and 8 hr after cimaterol or vehicle dosing. All samples were assayed for growth hormone (GH) and insulin, while samples taken at −4, −2, 0, +2, +4, +6 and +8 hr relative to dosing were assayed for thyroxine (T₄), triiodothyronine (T₃), cortisol, urea, glucose and non-esterified fatty acids (NEFA). Samples taken at −3 and +3 hr relative to dosing were assayed for IGF-I only. On day 1, cimaterol acutely reduced (P<.05) GH and urea concentrations (7.6 vs 2.9 ± 1.4 ng/ml; and 6.0 vs 4.9 ± 0.45 mmol/l, respectively; mean control vs mean treated ± pooled standard error of difference), and increased (P<.05) NEFA, glucose and insulin concentrations (160 vs 276 ± 22 μmol/l, 4.1 vs 6.2 ± 0.15 mmol/l and 29.9 vs 179.7 ± 13.9 μU/ml, respectively). Plasma IGF-I, T₃, T₄ and cortisol concentrations were not altered by treatment. On day 13, cimaterol increased (P<.05) GH and NEFA concentrations (7.7 vs 14.5 ± 1.4 ng/ml and 202 vs 310 ± 22 mEq/l, respectively) and reduced (P<.05) plasma IGF-I concentrations (1296 vs 776 ± 227 ng/ml). Seven-d withdrawal of cimaterol (day 20) returned hormone and metabolite concentrations to control values. It is concluded that : 1) cimaterol acutely increased insulin, glucose and NEFA and decreased GH and urea concentrations, 2) cimaterol chronically increased GH and NEFA and decreased IGF-I concentrations, and 3) there was no residual effect of cimaterol following a 7-d withdrawal period.     

Relationships between the thyroid and somatotropic axes in steers I: Effects of propylthiouracil-induced hypothyroidism on growth hormone, thyroid stimulating hormone and insulin-like growth factor I

The effects of propylthiouracil (PTU)-induced thyroid hormone imbalance on GH, TSH and IGF-I status in cattle were examined. In the first study, four crossbred steers (avg wt 350 kg) were fed a diet dressed with PTU (0, 1, 2 or 4 mg/kg/d BW) in a Latin square design with four 35-d periods. On day 29 in each period, steers were challenged with an intrajugular bolus of thyrotropin releasing hormone (TRH, 1.0 μg/kg). Blood samples were obtained to assess the change in plasma GH and TSH as affected by PTU. Plasma IGF-I was measured from blood samples obtained before and after (every 6 hr for 24 hr) intramuscular injection of bovine GH (0.1 mg/kg, day 31). Doses of 1 and 2 mg/kg PTU increased plasma T₄ (P<.01). At 4 mg/kg, PTU depressed T₄ concentrations to 30% of control (P<.01). Plasma T₃ linearly decreased with increasing doses of PTU (P<.01). Plasma TSH increased when PTU was fed at 4 mg/kg (P<.05) while the TSH response to TRH declined with increasing PTU (P<.02). Neither basal nor TRH-stimulated plasma concentration of GH was affected by PTU; the IGF-I response to GH tended to increase at the 1 and 2 mg/kg PTU (P<.01). In a second study 24 crossbred steers were fed PTU (1.5 mg/kg) for 119 d in a 2 × 2 factorial design with implantation of the steroid growth effector, Synovex-S (200 mg progesterone + 20 mg estradiol), as the other main effect. Basal plasma GH and IGF-I were not affected by PTU treatment. Synovex increased plasma concentration (P<.01) of IGF-I without an effect on plasma GH. The data suggest that mild changes in thyroid status associated with PTU affects regulation of T₃, T₄ and TSH more than GH or IGF-I in steers.     

Effect of exogenous thyrotropin-releasing hormone (TRH) administration on plasma levels of triiodothyronine (T3), thyroxine (T4) and growth hormone (GH) in chronically catheterized suckling piglets.

The purpose of the present study was to determine experimental conditions to stimulate secretion of thyroid hormones (T₃ and T₄) with thyrotropin-releasing hormone (TRH) injections in suckling piglets during the first weeks of postnatal life. Three consecutive experiments were conducted. Four 10–20 d old piglets were i.m. injected with 0, 20, 100, 500 μg (experiment 1) or 0, 4, 20, 100 μg TRH/kg BW (experiment 2) according to a 4 × 4 latin square design involving different litters in each experiment. Blood samples were taken −15, −1, 15, 30, 45, 60, 90, 120 180 and 300 min after TRH injection in experiment 1, and −.25, −.08, .25, .5, 1, 2, 4, 6, 8, 12, 24, 30, 36, 48, 60 and 72 hr after TRH injection in experiment 2. T₃ and T₄ levels were significantly (P<.01) increased as soon as 30 and 45 min after TRH injection, respectively. Maximal levels of T₃ and T₄ were obtained 2 and 4 hr after the injection of 100 μg TRH. T₃ and T₄ returned to basal levels within 6 and 8 hr post injection, respectively. Plasma pGH levels were significantly (P<.001) increased 15 min after TRH injection in piglets injected with 500 μg. In experiment 3, 100 μg TRH/kg BW were injected i.m. either daily or every other day from .0 to 23 days of age. Results showed that T₄ response to TRH did not decrease after repeated injections. These results indicate that daily i.m. injections of 100 μg TRH/kg BW can be used to increase thyroid hormone levels for at least 13 d in the young suckling piglet.     

Synergism and diurnal variations of human growth hormone-releasing factor (1-29)NH2 and thyrotropin-releasing factor on growth hormone release in dairy calves

Sixteen male Holstein calves averaging 168 kg body weight (BW) were used to determine the effects of human growth hormone-releasing factor (1–29)NH₂ (hGRF (1–29)NH₂; .22 μg/kg BW), thyrotropin-releasing factor (TRF; .165 μg/kg BW) or hGRF (1–29)NH₂ plus TRF (.22 and .165 μg/kg BW, respectively) on growth hormone (GH) release in animals exposed to 16 hr of light (L): 8 hr of dark (D) (lights on at 0100 hr) and hGRF plus TRF (.22 and .165 μg/kg BW, respectively) in animals exposed to 8L:16D (lights on at 0900 hr). For each treatment, times of iv injection were 0400, 1000, 1600 and 2200 hr. In animals exposed to 16L:8D, average GH peaks reached after hGRF (1–29)NH₂ or TRF injections were 49.7 and 32.0 ng/ml while the area under the GH response curve (AUC) were 1247 and 1019 ng/ml^*min, respectively. There was no significant effect of times of injection on GH release following the separate injection of hGRF (1–29)NH₂ or TRF. In animals exposed to 16L:8D, GH peaks and AUC after hGRF plus TRF injections were 226.4, 189.2 and 116.8 ng/ml, and 4340, 3660 and 2415 ng/ml^*min at 0400, 1000 and 1600 hr (lights on), respectively but only 42.3 ng/ml and 1692 ng/ml^*min at 2200 hr (lights off). In animals exposed to 8L:16D, GH levels and AUC after hGRF plus TRF injections reached 177.5 and 180.5 ng/ml, and 2759 and 3704 ng/ml^*min at 1000 and 1600 hr (lights on) but only 84.0 and 72.7 ng/ml, and 1544 and 1501 ng/ml^*min at 0400 and 2200 hr (lights off), respectively. These results demonstrated that hGRF (1–29)NH₂ and TRF can act in synergy to potentiate GH release in dairy calves. This synergistic action occurred only when both peptides were injected during the lighted phase of short and long day photoperiods.     

The influence of methimazole on the thyrotrophic and peripheral activity of thyrotrophin and thyrotrophin-releasing hormone in the chick embryo and growing chicken

Plasma concentrations of thyroxine (T₄) and triiodothyronine (T₃) were profoundly depressed both in chick embryos and growing chickens after methimazole (MMI) treatment. There was no response of T₄ and T₃ levels to TRH or TSH injections in the MMI group, either in embryos or growing chickens.

Peroxidase activity measured in the thyroid gland was significantly higher in embryos and growing chickens treated with MMI. However, neither TRH nor TSH affected this activity 2 hr after injection in either control or the MMI-treated group.

Hepatic 5′-monodeiodinase activity was significantly stimulated in the MMI-treated groups of embryos and growing chickens but only when additional sulphydryl groups (DTT) were provided. In embryos, monodeiodination activity 2 hr after TSH injection was not significantly different from control values for either DTT-stimulated or unstimulated conditions within the control and MMI-infused groups. However, in both control and MMI-treated embryos monodeiodination activity significantly increased 2 hr after TRH injection. In the growing chickens, monodeiodination activity 2 hr after TRH or TSH injection was not significantly different from control values in either stimulated or unstimulated conditions of each group.     

Effect of progressive cachectic parasitism and growth hormone treatment on hepatic 5'-deiodinase activity in calves

Thyroid status is compromised in a variety of acute and chronic infections. Conversion of thyroxine (T₄) into the metabolically active hormone, triiodothyronine (T₃), is catalyzed by 5′-deiodinase (5′D) mainly in extrathyroidal tissues. The objective of this study was to examine the effect of protozoan parasitic infection (Sarcocystis cruzi) on hepatic 5′D (type I) activity and plasma concentrations of T₃ and T₄ in placebo- or bovine GH (bGH)-injected calves. Holstein bull calves (127.5±2.0 kg BW) were assigned to control (C, ad libitum fed), infected (I, 250,000 S. cruzi sporocysts per os, ad libitum fed), and pair-fed (PF, non-infected, fed to intake of I treatment) groups placebo-injected, and three similar groups injected daily with pituitary-derived bGH (USDA-B-1, 0.1 mg/kg, i.m.) designated as C_GH, I_GH and PF_GH. GH injections were initiated on day 20 post-infection (PI), 3–4 days prior to the onset of clinical signs of the acute phase response (APR), and were continued to day 56 PI at which time calves were euthanized for liver collection. Blood samples were collected on day 0, 28, and 55 PI. Alterations in nutritional intake did not affect type I 5′D in liver. Treatment with bGH increased (P<0.05) 5′D activity in C (24.6%) and PF (25.5%) but not in I calves. Compared to PF calves, infection with S. cruzi reduced 5′D activity 25% (P<0.05) and 47.8% (P<0.01) in placebo- and bGH-injected calves, respectively. Neither nutrition nor bGH treatment significantly affected plasma concentrations of T₄ and T₃ on day 28 and 55 PI. However, plasma thyroid hormones were reduced by infection. On day 28 PI, the average plasma concentrations of T₃ and T₄ were reduced in infected calves (I and I_GH) 36.4% (P<0.01) and 29.4% (P<0.05), respectively, compared to pair-fed calves (PF and PF_GH). On day 55 PI, plasma T₃ still remained lower (23.7%, P<0.01 versus PF) in infected calves while plasma T₄ returned to control values. The data suggest that parasitic infection in growing calves inhibits both thyroidal secretion and extrathyroidal T₄ to T₃ conversion during the APR. After recovery from the APR, thyroidal secretion returns to normal but basal and bGH-stimulated generation of T₃ in liver remains impaired.     

The effect of insulin and relaxin upon mitosis (in vitro) in mammary tissue from pregnant and lactating pigs

The rate of cellular proliferation in the mammary glands of pigs during late gestation and lactation was assessed by measuring the incorporation of ³H-thymidine (T₁) into the DNA of mammary gland explants in vitro. The T₁ showed a linear response over the first 9 hr in vitro, and was not affected by the addition of 500 ng insulin/ml medium. From day 100 to parturition the T₁ rose, reached a peak at 2 d after parturition and declined during lactation to the lowest levels seen at day 21 of lactation.

The inclusion of 0–1000 ng relaxin/ml medium on T₁ at 24–72 hr in vitro had no effect in stimulating T₁ in mammary tissue explants taken from either pregnant or lactating pigs.     

The effect of dietary yeast and protected methionine on performance and trace minerals status of growing Awassi lambs

Eighteen growing Awassi lambs were used in this study to determine the effect of supplementing two levels of yeast and methionine (cyc-methionine) on the trace elements bioavailability, growth rate, and general performance. The lambs were divided to three groups. The dietary treatments were the control diet (C), control diet plus 2 g cyc-methionine/lamb/day (T₁) and control diet plus 4 g cyc-methionine/lamb/day (T₂).

Lambs fed 2 g/day of cyc-methionine (T₁) showed a significantly higher (P < 0.05) copper, zinc, and cobalt concentrations in liver and meat tissues, but not the same trend in kidney. No significant (P > 0.05) effect of time and time × treatment interaction on copper, zinc, cobalt, and manganese concentrations in blood serum, but cobalt and manganese concentration showed significant (P < 0.05) change by time. Moreover, a significantly (P < 0.05) higher total body gain, average daily gain, dressing percentage, and lower feed conversion were detected in lambs from T₁ compared with the control and T₂ groups.

Feeding 2 g of cyc-methionine to growing lambs increased the net profit by $6.017/lamb and only $3.52/lamb fed 4 g cyc-methionine/day when compared with the control group.

In conclusion, feeding growing Awassi lambs yeast and methionine in a form of cyc-methionine, with a low level of 2 g/day, improve the bioavailability of copper, zinc, and cobalt by growing lambs and their growth performance.     

Effects of winter nutrition and summer pasture or a feedlot diet on plasma Insulin-like Growth Factor I (IGF-I) and the relationship between circulating concentrations of IGF-I and thyroid hormones in steers

Effects of two winter nutritional levels (LOW, MOD) and two summer pastures (bahiagrass, BG; perennial peanut, PP) on plasma IGF-I, and the relationship between IGF-I and average daily gain (ADG), thyroid hormones, plasma urea, packed cell volume (PCV) and steer type were determined in 101 steers (217 kg) varying in breed composition, frame size and initial condition. Relationships between body composition or composition of gain and IGF-I were determined in 11 contemporary steers assigned directly to the feedlot. Initial IGF-I (57.9 ± 3.5 ng/ml) was positively correlated (P<.05) to initial condition, estimated percentage of Brahman and plasma T₃, but not related to subsequent ADG. During the 126-day wintering period, ADG was .21 kg for the LOW winter treatment and .47 kg for the MOD winter treatment. Concentration of IGF-I in the wintering period was affected (P<.01) by nutritional level (LOW = 71.8 ng/ml, MOD = 150.6 ng/ml) and was positively related to winter ADG in MOD steers (P<.01) but not in LOW steers. Concentration of IGF-I in winter was also positively related to condition at the end of the winter period (P<.01), T₃ (P<.05) and T₄ (P<.05). There were no effects of winter treatment on IGF-I during the subsequent summer pasture period. During the 145-d summer period, ADG was .53 kg for BG and .68 kg for PP. Concentration of IGF-I during the summer period was affected (P<.05) by pasture treatment (BG = 138.6 ng/ml, PP = 181.9 ng/ml), was positively related (P<.01) to PCV and percentage of Brahman, and was negatively related (P<.05) to estimated percentage of English breeding. In steers assigned directly to the feedlot, IGF-I was correlated with empty body (EB) weight (r=−.59, P<.10), EB water (r=−.59, P<.10) and EB protein (r=−.60, P<.10) at slaughter, and with days on feed (r=−.65, P<.05), but was not correlated with ADG or rate of component gain. These data indicate that IGF-I is related to nutritional status in steers as in other species, that there may be significant breed or cattle type differences in circulating concentrations of IGF-I, and that circulating concentration of IGF-I may be functionally related to plasma concentration of thyroid hormones.     

In vitro studies of the effect of propylthiouracil and ronnel on thyroxine-5'-monodeiodinase activity in steers

This study compares in vitro effects of propylthiouracil (PTU) and ronnel on the conversion of thyroxine (T4) to triiodothyronine (T3) in liver and kidney from Angus steers. Tissues were homogenized and incubated with T4 (1.3 microM) in the presence of 0 to 59 microM PTU or 0 to 49.7 microM ronnel. The T3 generated during a 30-min incubation was measured by radioimmunoassay. It was found that 1.47, 5.9 and 59 microM PTU decreased T4 to T3 conversion in liver and kidney by 62 and 88, 71 and 100, and 81 and 100%, respectively. The inhibition caused by 1.47 and 5.9 microM PTU was overcome by addition of 2 mM dithiothreitol (DTT). Ronnel in concentrations of 1.24, 6.22, 49.7 microM decreased T4 to T3 conversion in liver and kidney 46 and 45, 51 and 72, and 78 and 95%, respectively. However, with ronnel, the addition of DTT caused further inhibition. A Lineweaver-Burk plot of the data obtained using .32 to 6.43 microM T4 with 1.47 and 5.9 microM PTU or 6.22 and 12.44 microM ronnel indicated that PTU is an uncompetitive inhibitor (Ki = 1.67 microM) and ronnel is a noncompetitive (Ki = 15.5 microM) inhibitor of T4-5'-monodeiodination. The data suggest that decreased conversion of T4 to T3 by PTU or ronnel may be responsible for the increased plasma concentrations of T4 and slightly decreased plasma concentrations of T3 reported in steers treated with levels of both PTU and ronnel that are associated with growth stimulation.     

Characterization of and radioimmunoassay for canine thyroglobulin

Canine thyroglobulin (cTg) has been isolated and purified. It has similar electrophoretic patterns as Tg from other mammalian species. The main fraction had a MW of 660,000, whereas also fractions of a MW of approximately 1,300,000 (dimer) and 330,000 (subunit) were present. The iodine content was 0.8 to 1.0 % (w/w). cTg did not cross-react with antibodies against human Tg to a degree that would allow the use of a radioimmunoassay for human Tg for the determination of cTg in serum or plasma. Therefore a polyclonal antiserum was raised against cTg and a homologous radioimmunoassay was developed, which was sensitive (0.4 μg/l) and specific (cross-reactivity in cTg assay of human Tg, goat Tg, T₄, T₃, and DIT < 0.01 %).

Plasma Tg levels in normal dogs of both sexes and aged 3–15 years amounted to 192 ± 73 μg/l (mean ± SD, n=30). There was no relation between plasma Tg and T₄ levels.     

Dose effect of human growth hormone-releasing factor and thyrotropin-releasing factor on hormone concentrations in lactating dairy cows

Two experiments were conducted to study the effects of growth hormone-releasing factor (GRF) and thyrotropin-releasing factor (TRF) administration on hormone concentrations in dairy cows. In the first trial, 12 cows were used on 5 consecutive days to determine the effect of four sc doses of GRF (0, 1.1, 3.3 and 10 μg•kg⁻¹ BW) and three sc doses of TRF (0, 1.1 and 3.3 μg•kg⁻¹ BW) combined in a factorial arrangement. GRF and TRF acted in synergy (P = .02) on serum growth hormone (GH) concentration even at the lowest dose tested and GH response to the two releasing factors was higher than the maximal response observed with each factor alone. TRF increased (P<.01) prolactin (Prl), thyrotropin (TSH), triiodothyronine (T₃) and thyroxine (T₄) concentrations similarly at the 1.1 and 3.3 μg•kg⁻¹ doses and GRF did not interact (P>.40) with TRF on the release of these hormones. In the second trial, the effect of GRF (3.3 μg•kg⁻¹ BW, sc) and TRF (1.1 μg•kg⁻¹ BW, sc) was tested at three stages (18, 72 and 210 days) of lactation on serum Prl and TSH concentrations. Eighteen cows (n = 6 per stage of lactation) were used in two replicates of a 3 × 3 latin square. The TRF and GRF-TRF treatments were equipotent (P>.05) in increasing Prl and TSH concentrations. Prl and TSH responses were similar (P>.40) throughout lactation. In summary, GRF at doses ranging from 1.1 to 10.0 μg•kg⁻¹ and TRF at doses ranging from 1.1 to 3.3 μg•kg⁻¹ act in synergy on GH release and do not interact on Prl, TSH, T₃ and T₄ concentrations in dairy cows. Furthermore, Prl and TSH response to TRF are not affected by stage of lactation.     

Adenohypophyseal receptors for LHRH, pituitary content of gonadotropins and plasma concentrations of LH in cyclic, pregnant and postpartum beef cows

Adenohypophyseal concentrations of LHRH receptors, pituitary content of LH and FSH, and plasma concentrations of LH were determined in thirty Hereford, Angus or Hereford-Angus heifers that were randomly assigned by breed and weight to five periods including day 3 of the estrous cycle (CY), pregnant day 120 (P120), 200 (P200), 275 (P275), or day 2 postpartum (PP). Jugular blood samples were collected at 10-min intervals for 8 hr from all cows. Within 2 hr after completion of blood sampling, animals were slaughtered and the pituitary gland frozen at −196 C. LH pulse frequency/8 hr was reduced (P<.05) during gestation (.5, .2, and 1.5 ± .5/8 hr, for P120, P200, and P275, respectively) and PP (.5 ± .5/8 hr) compared to CY (7.8 ± .5/8 hr). Frequency of LH pulses/8 hr was not different (P>.1) among P120, P200 or PP periods but was different (P<.05) between P200 and P275. There were no differences in LH pulse height (P>.1) among periods; however, pulse amplitude was greatest (P<.05) at P120 (1.3 ± .2 ng/ml) and lowest between P200 and PP (.6 to .8 ± .2 ng/ml). Baseline concentrations of plasma LH did not differ (P>.1) among P and PP periods (.3 ± .1 ng/ml), but were lower (P<.05) than in CY animals (.7 ± .1 ng/ml). Concentration of adenohypophyseal LHRH receptors was approximately two-fold greater (P<.05) at P120 (25.85 ± 2.2 fmol/mg) than at all other periods (9.5 to 14.9 ± 2.2 fmol/mg). Pituitary content of LH was greatest at P120 (1.56 ± .11 ug/mg) and lowest (P<.05) at P275 and PP (0.46 to 0.52 ± .11 ug/mg). Pituitary content of FSH was greatest (P<.05) in P (12.7 to 17.0 ± 1.4 ug/mg) and PP (18.3 ± 1.4 ug/mg) vs CY (5.0 ± 1.4 ug/mg) cows and increased from P120 to PP (P<.05). Results indicate that physiological changes occurring during gestation may have an effect on subsequent function of the adenohypophysis in beef cows.     

Physical and chemical components of the empty body during compensatory growth in beef steers

The composition of carcass and noncarcass tissue growth was quantified by serial slaughter of 26 Angus x Hereford crossbred steers (initial age and weight 289 +/- 4 d and 245 +/- 4 kg) during continuous growth (CON) or compensatory growth (CG) after a period of growth restriction (.4 kg/d) from 245 to 325 kg BW. All steers were fed a 70% concentrate diet at ad libitum or restricted levels. Homogenized samples of 9-10-11th rib and noncarcass tissues were analyzed for nitrogen, fat, ash, and moisture. Growth rate from 325 to 500 kg BW was 1.54 and 1.16 kg/d for CG and CON steers. The weight of gut fill in CG steers was 10.8 kg less (P less than .05) before realimentation and 8.8 kg more (P less than .10) at 500 kg BW than in CON steers. The allometric accretive rates for carcass chemical components relative to the empty body were not affected by treatment. However, the accretive rates for CG steers were greater (P less than .01) for noncarcass protein (.821 vs .265), noncarcass water (.861 vs .507), and empty-body protein (.835 vs. .601) than for CON steers. Final empty-body fat was lower (P less than .001; 24.2 vs 32.4%) and empty-body protein higher (P less than .001; 16.6 vs 14.8%) in CG steers than in CON steers. Consequently, net energy requirements for growth (NEg) were approximately 18% lower for CG steers. We conclude that reduced NEg requirements and changes in gut fill accounted for most of the compensatory growth response exhibited in these steers.     

Total and free iodothyronine levels of growing Thoroughbred foals: Effects of weaning and gender

The aim of this study was investigate the effect of growing associated with different gender on circulating total and free iodothyronine concentrations during the first 13 mo of age in foals. In addition, we investigated the evolution of circulating concentrations of thyroid hormones during the first 3 d of weaning. Blood was collected from 13 clinically healthy Thoroughbred foals every month. All foals were weaned at the 4 mo and blood samples were taken also at 24, 48 and 72 h after weaning. The results obtained showed growing effects for tri-iodothyronine (T₃), thyroxine (T₄), free tri-iodothyronine (fT₃) and free thyroxine (fT₄) values (P < .001).

Serum T₃ concentrations averaged respectively 2.89 and 0.29 nmol/L at 7 and 9 mo. Serum T₄ concentrations averaged respectively 100.17 and 21.77 nmol/L at 1 and at 10 mo. Serum fT₃ concentrations averaged respectively 6.96 and 1.50 pmol/L at 1 and 4 mo. Serum fT₄ concentrations averaged respectively 31.40 and 4.93 pmol/L at 1 and 9 mo. Significant correlations between T₃, T₄, fT₃ and fT₄ with body weight (BW) and between T₃, T₄ and fT₄ with age were observed.

Weaning effects (P < .001) were shown for T₃ and fT₄ levels. No differences (P > .05) in T₄ and fT₃ levels were observed over the 3-day period. Gender effects (P < .001) were shown for T₃, T₄, fT₃, and fT₄ levels. Significant correlations between T₄ and fT₄ with BW and age were observed in colts and fillies. T₃ concentrations were correlated with age only in colts and fT₃ with BW only in colts. The results obtained seem to lend support to the recognized effects of growing and weaning in modulating the thyroid function of Thoroughbred foals. In fact, significant and differentiated effects of growing and weaning on total and free iodothyronine levels have been demonstrated.     

Effects of dietary copper concentration and source on performance and copper status of growing and finishing steers

Performance and Cu status were measured in growing and finishing steers supplemented with different copper (Cu) concentrations and sources. Sixty Angus (n = 36) and Angus x Hereford (n = 24) steers were stratified by weight and initial liver Cu concentration within a breed and randomly assigned to treatments. Treatments consisted of 1) control (no supplemental Cu); 2) 20 mg Cu/kg DM from Cu sulfate (CuSO4); 3) 40 mg Cu/kg DM from CuSO4; 4) 20 mg Cu/ kg DM from Cu citrate (C6H4Cu2O7); 5) 20 mg Cu/kg DM from Cu proteinate; and 6) 20 mg Cu/kg DM from tribasic Cu chloride (Cu2(OH)3Cl). A corn silage-soybean meal-based diet that was analyzed to contain 10.2 mg of Cu/kg DM was fed for 56 d. Steers were then switched to a high-concentrate diet that was analyzed to contain 4.9 mg of Cu/kg DM. Equal numbers of steers per treatment were slaughtered after receiving the finishing diets for either 101 or 121 d. Performance was not affected by Cu level or source during the growing phase. Gain, feed intake, and feed efficiency were reduced (P < .05) by Cu supplementation during the finishing phase. Plasma and liver Cu concentrations were higher in steers receiving supplemental Cu at the end of both the growing and finishing phases. Steers supplemented with 40 mg Cu/kg DM from CuSO4 had higher (P < .05) liver Cu concentrations than those supplemented with 20 mg Cu/kg DM from CuSO4. Liver Cu concentrations did not increase over the finishing phase relative to liver Cu concentrations at the end of the growing phase. These results indicate that as little as 20 mg/kg of supplemental Cu can reduce performance in finishing steers.     

Perturbed metabolism and hormonal profiles in calves infected with Sarcocystis cruzi

Plasma concentrations of growth hormone (GH), thyroid stimulating hormone (TSH), insulin (IN), thyroxine (T₄), and triiodothyronine (T₃) in addition to metabolic parameters [N balance (NB), urinary 3-methylhistidine (TMH), urinary creatinine (CR), and urinary hydroxyproline (HP)] were measured in 4-mo-old Holstein steers divided equally among groups infected with Sarcocystis (I), noninfected ad libitum fed (C), and noninfected pair fed to I (PF) (7 steers per treatment). Effects of infection on these parameters beyond those attributable to altered dietary intake were determined using orthogonal contrasts (effect of intake, C vs I + PF; effect of infection, PF vs I). NB was higher in C than I and PF (P<.05) and lower in I than PF (P<.02). Hydroxyproline and CR were influenced by intake (P<.05) and HP excretion was reduced in association with infection (P<.05). Reduced intake was associated with lowered mean basal plasma concentrations of GH, IN, T₃ and T₄ (P<.05). Infection further reduced (P<.001) plasma T₃ concentration.

Triiodothyronine and T₄ responses following an intravenous bolus of thyrotropin releasing hormone (TRH) were measured. The magnitude of the responses in I and PF were lower than those observed in C (P<.05). Plasma T₃ responses were further reduced in association with infection (P<.05). Insulin responses to intravenous arginine infusion (ARG) were also low in association with reduced intake. Growth hormone responses to TRH or ARG were affected by the level of feed intake only. These data suggest that hormonal perturbations associated with the insult of infection further compromise metabolism and the direction of nutrient partitioning that would ordinarily be associated with developmental growth in young steers beyond those responses anticipated from solely the reduction of feed intake.     

Purification and partial characterization of thyroid hormone binding proteins in canine serum

Thyroxine-binding prealbumin (TBPA) and thyroxine-binding globulin (TBG) were isolated from canine serum and partially characterized. TBPA was isolated by retinol-binding protein (RBP) affinity chromatography and further purified by preparative agarose gel electrophoresis or FPLC ion exchange chromatography. TBG was purified by thyroxine (T₄)-Sepharose chromatography followed by gel filtration on Sephacryl S-300 and preparative electrofocusing in a granulated dextran gel. Molecular weights were estimated by SDS-polyacrylamide gradient gel electrophoresis. Canine TBPA had a tetramer molecular weight of 56,000, an extinction coefficient of 12.8 cm²cg⁻¹, an isoelectric point of 5.26–5.70 and a microheterogeneity pattern similar to that of human TBPA. Partial immunochemical identity with human TBPA was also found. Plasma concentrations of TBPA were measured by rocket immunoelectrophoresis in 43 normal and 35 hypothyroid dogs. Reference levels for TBPA ranged between 205 and 474 mg/l. Hypothyroid dogs had a mean TBPA level of 315.0 mg/l (SD: 91.1 mg/l). TBG had a molecular weight of 75,000 and an isoelectric point of 5.0. No immunochemical identity with human TBG was found. Gel filtration of serum on Sephacryl S-200, identification of T₄-binding proteins with ¹²⁵I-T₄, and protein- and lipoprotein staining of fractions was performed. Thyroxine-binding was found to TBG in the β-globulin region, TBPA in the ₂-region, albumin, and to the high density lipoprotein (HDL₂) in the ₁-region and the very low density lipoprotein (VLDL) in the pre-β region. A corresponding band to the latter protein in serum was masked by TBG and TBPA, and T₄-binding in the ₁-region was not always seen in serum. Many similarities were found between man and dog regarding TBPA, but not TBG. The differences in structure of TBG may in part be responsible for the low serum T₄ levels and rapid T₄ metabolism seen in dogs.